Abstract
Zinc is an essential requirement for normal cellular processes and is involved in the function of more than 300 enzymes. Currently, it is estimated that approximately 10 % of the proteins encoded by the human genome contain zinc. Zinc is necessary for neuromodulation, synaptic transmission, intracellular signal transduction, and myriad other processes. The clinical implications of impaired zinc signaling are, therefore, far reaching, with profound central and peripheral disorders arising as a result of either an acute or a long-term dyshomeostasis in normal zinc levels. Targeting zinc as a therapy is now emerging as a tantalizing, although especially difficult, approach to a variety of diseases, including central nervous system disorders. This chapter reviews the clinical implications of impaired zinc signaling in the brain.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes A et al (2008) Rapid restoration of cognition in Alzheimer’s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ. Neuron 59:43–55
Adlard PA, Parncutt JM, Finkelstein DI, Bush AI (2010) Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits in Alzheimer’s disease? J Neurosci 30(5):1631–1636
Adlard PA, Sedjahtera A, Gunawan L, Bray L, Hare D, Lear J et al (2013) A novel approach to rapidly prevent age-related cognitive decline. Aging Cell. doi:10.1111/acel.12178
Andreini C, Banci L, Bertini I, Rosato A (2006) Counting the zinc-proteins encoded in the human genome. J Proteome Res 5:196–201
Bin B-H, Fukada T, Hosaka T, Yamasaki S, Ohashi W, Hojyo S et al (2011) Biochemical characterisation of human ZIP13 protein: a homo-dimerized zinc transporter involved in the spondylocheiro dysplatic Ehlers–Danlos syndrome. J Biol Chem 286(46):40255–40265
Cousins RJ, Lichten LA (2011) Zinc transporters. In: Rink L (ed) Zinc in human health. IOS Press, Amsterdam, pp 136–162
Cousins RJ, Liuzzi JP, Lichten LA (2006) Mammalian zinc transport, trafficking and signals. J Biol Chem 281(34):24085–24089
Ding W-Q, Lind SE (2009) Metal ionophores: an emerging class of anticancer drugs. Life 61(11):1013–1018
Eide DJ (2004) The SLC39 family of metal ion transporters. Eur J Physiol 447:796–800
Fukada T, Yamasaki S, Nishida K, Murakami M, Hirano T (2011) Zinc homeostasis and signalling in health and diseases. J Biol Inorg Chem 16:1123–1134
Gaither LA, Eide DJ (2001) Eukaryotic zinc transporters and their regulation. In: Maret W (ed) Zinc biochemistry, physiology and homeostasis. Springer, Dordrecht, pp 65–84
Galvez-Peralta M, Wang Z, Bao S, Knoell DL, Nebert DW (2014) Tissue-specific induction of mouse ZIP8 and ZIP14 divalent cation/bicarbonate symporters by, and cytokine response to, inflammatory signals. Int J Toxicol 33:246–258
Giunta C, Elcioglu NH, Albrecht B, Eich G, Chambaz C, Janecke AR et al (2008) Spondylocheiro dysplastic form of the Ehlers–Danlos syndrome: an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13. Am J Hum Genet 82(6):1290–1305
Grabrucker AM, Rowan A, Garner CC (2011) Brain-delivery of zinc-ions as potential treatment for neurological diseases: mini review. Drug Deliv Lett 1(1):13–23
Greenough MA, Camakaris J, Bush AI (2013) Metal dyshomeostasis and oxidative stress in Alzheimer’s disease. Neurochem Int 62(5):540–555
Haase H, Rink L (2011) Zinc signalling. In: Rink L (ed) Zinc in human health. IOS Press, Amsterdam, pp 94–117
Hennigar SR, Kelleher SL (2012) Zinc networks: the cell-specific compartmentalization of zinc for specialised functions. Biol Chem 393:565–578
Hirano T, Murakami M, Fukada T, Nishida K, Yamasaki S, Suzuki T (2008) Roles of zinc and zinc signalling in immunity: zinc as an intracellular signalling molecule. Adv Immunol 97:149–176
Jeong J, Eide DJ (2013) The SLC39 family of zinc transporters. Mol Asp Med 34:612–619
Jeong J, Walker JM, Wang F, Park JG, Palmer AE, Giunta C et al (2012) Promotion of vesicular zinc efflux by ZIP13 and its implications for spondylocheiro dysplastic Ehlers–Danlos syndrome. Proc Natl Acad Sci USA 109(51):E3530–E3538
Kambe T (2012) Molecular architecture and function of ZnT transporters. Curr Top Membr 69:199–220
Karol N, Brodski C, Bibi Y, Kaisman T, Forberg M, Hershfinkel M et al (2010) Zinc homeostatic proteins in the CNS are regulated by crosstalk between extracellular and intracellular zinc. J Cell Physiol 224:567–574
King JC, Shames DM, Woodhouse LR (2000) Zinc homeostasis in humans. Am Soc Nutr Sci 1360S–1366S
Krebs NF (2000) Overview of zinc absorption and excretion in the human gastrointestinal tract. J Nutr 130(5):1374S–1377S
Levenson CW, Tassabehji NM (2007) Role and regulation of copper and zinc transport proteins in the central nervous system. In: Lajtha A (ed) Handbook of neurochemistry and molecular neurobiology. Plenum, New York
Lichten LA, Cousins RJ (2009) Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 29:153–176
Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong C-X (2009) Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s disease. J Neurochem 111(1):242–249
Li Y, Maret W (2009) Transient fluctuations of intracellular zinc ions in cell proliferation. Exp Cell Res 315:2463–2470
Liuzzi JP, Cousins RJ (2004) Mammalian zinc transporters. Annu Rev Nutr 24:151–172
Manso Y, Adlard PA, Carrasco J, Vasak M, Hidalgo J (2011) Metallothionein and brain inflammation. J Biol Inorg Chem 16:1103–1113
Maret W, Sandstead HH (2006) Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 20(1):3–18
Martel G, Hevi C, Kane-Goldsmith N, Shumyatsky GP (2011) Zinc transporter ZnT3 is involved in memory dependent on the hippocampus and perirhinal cortex. Behav Brain Res 223:233–238
McBean LD, Dove JT, Halsted JA, Smith JC Jr (1972) Zinc concentration in human tissues. Am J Clin Nutr 25:672–676
Mocchegiani E, Malavolta M (2011) Zinc and ageing. In: Rink L (ed) Zinc in human health. IOS Press, Amsterdam, pp 325–346
Mocchegiani E, Giaconni R, Cipriano C, Muzzioli M, Fattoretti P, Bertoni-Freddari C et al (2001) Zinc-bound metallothioneins as potential biological markers of ageing. Brain Res Bull 55(2):147–153
Netsky MG, Harrison WH, Brown M, Benson C (1969) Tissue zinc and human disease. Relationship of zinc content of kidney, liver and lung to atherosclerosis and hypertension. Am J Clin Pathol 51:358
Nolte C, Gore A, Sekler I, Kresse W, Hershfinkel M, Hoffman A et al (2004) ZnT1 expression in astroglial cells protects against zinc toxicity and slows the accumulation of intracellular zinc. Glia 43:145–155
Nyaradi A, Li J, Hickling S, Foster J, Oddy WH (2013) The role of nutrition in children’s neurocognitive development, from pregnancy through childhood. Front Hum Neurosci 7:97
Paoletti P, Vergnano AM, Barbour B, Casado M (2009) Zinc at glutamatergic synapses. Neuroscience 158:126–136
Perafan-Riveros C, Franca FS, Alves CF, Sanches JA Jr (2002) Acrodermatitis enteropathica: case report and review of the literature. Pediatr Dermatol 19(5):426–431
Prasad AS, Miale A, Farid Z, Schulert A, Sandstead HH (1963) Zinc metabolism in patients with syndrome of iron deficiency anemia, hypogonadism and dwarfism. J Lab Clin Med 61:537–549
Raulin J (1869) Chemical studies on vegetation. Am Sci Nat 11:93–99
Roberts BR, Ryan TM, Bush AI, Masters CL, Duce JA (2012) The role of metallobiology and amyloid-β peptides in Alzheimer’s disease. J Neurochem 120(suppl 1):149–166
Sehgal VN, Jain S (2000) Acrodermatitis enteropathica. Clin Dermatol 18(6):745–748
Seaquist ER (2010) The final frontier: How does diabetes affect the brain? Diabetes 59:4–5
Shay NF, Mangan HF (2000) Neurobiology of zinc-influenced eating behaviour. J Nutr 130(5S suppl):1493S–1499S
Sindreu C, Palmiter RD, Storm DR (2011) Zinc transporter ZnT-3 regulates presynaptic Erk1/2 signaling and hippocampus-dependent memory. Proc Natl Acad Sci USA 108:3366–3370
Smith JL, Xiong S, Markesbery WR, Lovell MA (2006) Altered expression of zinc transporters 4- and 6- in mild cognitive impairment, early and late Alzheimer’s disease brain. Neuroscience 140:879–888
Staiger H, Machicao F, Stefan N, Tschritter O, Thamer C, Kantartzis K et al (2007) Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. Plos One 9:e832
Takeda A (2000) Zinc homeostasis and functions of zinc in the brain. Biometals 14:343–351
Takeda A, Tamano H (2009) Insight into zinc signalling from dietary zinc deficiency. Brain Res Rev 62:33–44
Takeda A, Tamano H (2012) Proposed glucocorticoid-mediated zinc signalling in the hippocampus. Metallomics 4:614–618
Tapiero H, Tew KD (2003) Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother 57(9):399–411
Thirumoorthy N, Shyam SA, Manisethil Kuma KT, Ganesh GNK, Chatterjee M (2011) A review of metallothioneins isoforms and their role in pathophysiology. World J Surg Oncol 9(54)
Vasto S, Candore G, Listi F, Balistreri CR, Colonna-Romano G, Malavolta M et al (2008) Inflammation, genes and zinc in Alzheimer’s disease. Brain Res Revs 58:96–105
Wang Z-Y, Stoltenberg M, Huang L, Danscher G, Dahlstrom A, Shi Y et al (2005) Abundant expression of zinc transporters in Bergman glia of mouse cerebellum. Brain Res Bull 64:441–448
Wong CP, Magnusson KR, Ho E (2013) Increased inflammatory response in aged mice is associated with age-related zinc deficiency and zinc transporter dysregulation. J Nutri Biochem 24:353–359
Wastney ME, Aamodt RL, Rumble WF, Henkin RI (1986) Kinetic analysis of zinc metabolism and its regulation in normal humans. Am J Physiol 251:R398–R408
Zhang L-H, Wang X, Zheng Z-H, Ren H, Stoltenberg M, Danscher G et al (2008) Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain. Neurobiol Aging 31:74–87
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Hancock, S.M., Bush, A.I., Adlard, P.A. (2014). The Clinical Implications of Impaired Zinc Signaling in the Brain. In: Fukada, T., Kambe, T. (eds) Zinc Signals in Cellular Functions and Disorders. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55114-0_9
Download citation
DOI: https://doi.org/10.1007/978-4-431-55114-0_9
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55113-3
Online ISBN: 978-4-431-55114-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)